Position in ACLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$269,440,056
+$116,439,780 QoQ
Shares Held
2,346,630
0.0% QoQ
Ownership
4.01%
of shares outstanding
% of Portfolio
29.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SR One Capital Management, LP holds $914,169,725 across 14 Biotechnology names. ACLX ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
This page
|
2,346,630 | $269,440,056 | |
| 2 | MANE |
Veradermics, Inc
|
2,401,868 | $151,677,964 | |
| 3 | ZBIO |
Zenas BioPharma, Inc.
|
5,037,854 | $98,490,045 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
2,038,763 | $96,983,955 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
6,526,476 | $69,441,704 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
4,514,929 | $57,204,150 | |
| 7 | ALMS |
Alumis Inc.
|
1,959,896 | $43,176,508 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
1,563,966 | $42,367,838 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $269,440,056 | 2,346,630 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $153,000,276 | 2,346,630 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $192,658,323 | 2,346,630 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $154,525,585 | 2,346,630 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $153,938,928 | 2,346,630 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $179,963,054 | 2,346,630 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $195,967,071 | 2,346,630 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $129,510,509 | 2,346,630 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $163,208,116 | 2,346,630 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $174,637,965 | 3,146,630 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $141,605,084 | 3,946,630 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $124,792,440 | 3,946,630 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $169,455,215 | 5,500,007 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $170,390,216 | 5,500,007 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $103,235,131 | 5,500,007 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $99,440,126 | 5,500,007 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $77,110,098 | 5,500,007 | Shares | Sole | 2022-05-10 | |
| No filing history on record for this holder in this stock. | ||||||